Two COVID-19 vaccines not enough for kidney failure patients: Research
The research highlights the urgent need for these patients to access a third and, if necessary, a fourth vaccine
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVID vaccine
67 per cent Indians believe ‘Made in India’ vaccines are safer than vaccines developed abroad: India…
Over 90 per cent of Indians believe that vaccine’s role is vital to fight against COVID-19 whereas over 85 per cent believes that…
Leiden University Medical Center and Intravacc to start clinical trial with new intranasal corona…
Intravacc will focus on a number of additional and preliminary preclinical exercises and the process development research of the…
Covaxin for children: Study demonstrates robust safety and immunogenicity in 2-18 volunteers
Covaxin is one of the first COVID-19 vaccines in the world to generate data in 2-18 year age group
Corbevax by Biological E gets DCGI approval
CORBEVAX is India’s 1st indigenously developed protein sub-unit COVID-19 vaccine
- Advertisement -
NIH scientists urge pursuit of universal coronavirus vaccine
Despite the availability of safe, effective COVID-19 vaccines, it remains unknown whether and how permanent immunity can be…
Research holds clues for future COVID vaccines
A study by Foundation of Medical Research FMR undertaken in collaboration with Municipal Corporation of Greater Mumbai (MCGM), Dr…
Capturing maximum value from drone delivery for medicines requires a combined effort from…
Dr Suresh Munuswamy, Head - Technology Innovations and Health Informatics, Public Health Foundation of India (PHFI) in an…
80 crore adult COVID-19 doses by December: Chair, COVAX Global Expert Group
20 crore monthly doses in September, 25 crores in October, and 35 crore each in November and December are expected
The third COVID vaccine dose: what do we know so far?
Dr. M.S.S. Mukharjee, Senior Interventional Cardiologist-Medicover Hospitals and Director - Pulse Heart Center & Pulse Heart…